aXichem AB
Stockholm Stock ExchangeTotal Valuation
aXichem AB carries a market capitalization of 143.59M, placing it among publicly traded companies globally. Its enterprise value stands at 91.16M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 143.59M |
| Enterprise Value | 91.16M |
Share Statistics
aXichem AB currently has 67.73M shares outstanding.
| Shares Outstanding | 67.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 5.04, and the price-to-book ratio stands at 7.02.
| PE Ratio | N/A |
| PS Ratio | 5.04 |
| PB Ratio | 7.02 |
| P/TBV Ratio | 6.84 |
| P/FCF Ratio | -8.45 |
| P/OCF Ratio | -8.45 |
Enterprise Valuation
| EV / Sales | 4.83 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
aXichem AB maintains a current ratio of 4.23, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.23 |
| Quick Ratio | 0.93 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -121.35 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -21.20 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.08 |
Taxes
| Income Tax | 27,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
aXichem AB's stock has declined approximately -27.89116% over the past 52 weeks. The 50-day moving average sits at 1.44, while the 200-day moving average is 1.88.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.89116% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.88 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, aXichem AB generated 18.89M in revenue and converted that into -14.64M in net income, yielding earnings per share of -0.24. EBITDA reached -14.44M, while operating income came in at -14.44M.
| Revenue | 18.89M |
| Gross Profit | 9.39M |
| Operating Income | -14.44M |
| Pretax Income | -14.62M |
| Net Income | -14.64M |
| EBITDA | -14.44M |
| EBIT | -14.44M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
Total book value stands at 13.55M, with working capital of 13.90M providing operational flexibility.
| Cash & Cash Equivalents | 4.00M |
| Total Debt | N/A |
| Net Debt | -4.00M |
| Equity (Book Value) | 13.55M |
| Book Value Per Share | 0.22 |
| Working Capital | 13.90M |
Cash Flow
aXichem AB produced -11.26M in operating cash flow over the past twelve months.
| Operating Cash Flow | -11.26M |
| Capital Expenditures | N/A |
| Free Cash Flow | -11.26M |
| FCF Per Share | -0.19 |
Margins
aXichem AB operates with a gross margin of 49.74, reflecting its pricing power and cost economics. The operating margin of -76.47 and net profit margin of -77.53 provide insight into operational efficiency.
| Gross Margin | 49.74 |
| Operating Margin | -76.47 |
| Pretax Margin | -77.39 |
| Profit Margin | -77.53 |
| EBITDA Margin | -76.47 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.82 |
| FCF Yield | -11.84 |
Stock Splits
aXichem AB's most recent stock split took place on March 7, 2024 with a 100:103 split ratio.
| Last Split Date | 3/7/2024 |
| Split Ratio | 100:103 |
Scores
aXichem AB posts an Altman Z-Score of 12.60, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.60 |